We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Board Cancels Claims Of Patent Covering Treatment For Lymphomas

Mealey's (October 5, 2018, 12:11 PM EDT) -- ALEXANDRIA, Va. — In a final written decision issued Oct. 4, the Patent Trial and Appeal Board agreed with an inter partes review (IPR) petitioner that six claims of a patented...
To view the full article, register now.